Chronic thromboembolic pulmonary hypertension: Emerging endovascular therapy

Keshav Menon, Patrick D. Sutphin, Sonja Bartolome, Sanjeeva P. Kalva, Takeshi Ogo

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


Chronic thromboembolic pulmonary hypertension (CTEPH) is a debilitating but potentially reversible complication of chronic pulmonary thromboembolic disease characterized by progressive right heart dysfunction secondary to pulmonary arterial stenosis or occlusion. Balloon pulmonary angioplasty (BPA) has recently emerged as an alternative intervention for non-surgical candidates with CTEPH. Modern reperfusion angioplasty techniques relieve sequela of chronic pulmonary hypertension, ameliorate right ventricular failure, and improve functional status. This article will discuss the diagnosis and treatment of patients with CTEPH and the current state of endovascular management with BPA.

Original languageEnglish (US)
Pages (from-to)272-278
Number of pages7
JournalCardiovascular Diagnosis and Therapy
Issue number3
StatePublished - Jun 2018


  • Balloon pulmonary angioplasty (BPA)
  • Chronic thromboembolic pulmonary hypertension (CTEPH)

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Chronic thromboembolic pulmonary hypertension: Emerging endovascular therapy'. Together they form a unique fingerprint.

Cite this